| PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma | |
| Feng, Jiao; Wu, Liwei; Ji, Jie; Chen, Kan; Yu, Qiang; Zhang, Jie; Chen, Jiaojiao; Mao, Yuqing; Wang, Fan; Dai, Weiqi | |
| 刊名 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
 |
| 2019 | |
| 卷号 | 38 |
| 关键词 | Proanthocyanidin B2 Hepatocellular carcinoma Aerobic glycolysis PKM2 Sorafenib |
| ISSN号 | 1756-9966 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3595970 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Feng, Jiao,Wu, Liwei,Ji, Jie,et al. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,38. |
| APA | Feng, Jiao.,Wu, Liwei.,Ji, Jie.,Chen, Kan.,Yu, Qiang.,...&Guo, Chuanyong.(2019).PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,38. |
| MLA | Feng, Jiao,et al."PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 38(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论